These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29561299)

  • 21. Mental disorders diagnosed in childhood and at-risk mental state in a help-seeking population.
    Comparelli A; Pucci D; Savoja V; Kotzalidis GD; Falcone I; Angelone M; Comazzetto C; Emili E; Rigucci S; Tatarelli R; Girardi P
    Early Interv Psychiatry; 2013 May; 7(2):187-92. PubMed ID: 22762367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery.
    Zhang T; Xu L; Tang Y; Cui H; Tang X; Wei Y; Wang Y; Hu Q; Qian Z; Liu X; Li C; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):871-877. PubMed ID: 29942980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis.
    Mourik K; Decrescenzo P; Brucato G; Gill KE; Arndt L; Kimhy D; Keilp JG; Girgis RR
    Early Interv Psychiatry; 2017 Jun; 11(3):250-254. PubMed ID: 26663764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of conversion rates, clinical profiles and predictors of outcomes in two independent samples of individuals at clinical high risk for psychosis in China.
    Li H; Zhang T; Xu L; Tang Y; Cui H; Wei Y; Tang X; Woodberry KA; Shapiro DI; Li C; Seidman LJ; Wang J
    Schizophr Res; 2018 Jul; 197():509-515. PubMed ID: 29287626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of psychosis in prodrome: development and validation of a simple, personalized risk calculator.
    Zhang T; Xu L; Tang Y; Li H; Tang X; Cui H; Wei Y; Wang Y; Hu Q; Liu X; Li C; Lu Z; McCarley RW; Seidman LJ; Wang J;
    Psychol Med; 2019 Sep; 49(12):1990-1998. PubMed ID: 30213278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.
    Tang SX; Yi JJ; Moore TM; Calkins ME; Kohler CG; Whinna DA; Souders MC; Zackai EH; McDonald-McGinn DM; Emanuel BS; Bilker WB; Gur RC; Gur RE
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):991-1000.e2. PubMed ID: 25151422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Young people at risk for psychosis: case finding and sample characteristics of the Oulu Brain and Mind Study.
    Veijola J; Mäki P; Jääskeläinen E; Koivukangas J; Moilanen I; Taanila A; Nordström T; Hurtig T; Kiviniemi V; Mukkala S; Heinimaa M; Lindholm P; Jones PB; Barnett JH; Murray GK; Miettunen J
    Early Interv Psychiatry; 2013 May; 7(2):146-54. PubMed ID: 22672385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and qualitative symptomatic differences in individuals at Ultra-High Risk for psychosis and healthy controls.
    Velthorst E; Derks EM; Schothorst P; Becker H; Durston S; Ziermans T; Nieman DH; de Haan L
    Psychiatry Res; 2013 Dec; 210(2):432-7. PubMed ID: 23938166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faux pas recognition performance in a help-seeking population at clinical high risk of psychosis.
    Zhang T; Yi Z; Li H; Cui H; Tang Y; Lu X; Xu L; Qian Z; Zhu Y; Jiang L; Chow A; Li C; Jiang K; Xiao Z; Wang J
    Eur Arch Psychiatry Clin Neurosci; 2016 Feb; 266(1):71-8. PubMed ID: 26189033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Violent Content in Attenuated Psychotic Symptoms.
    Marshall C; Deighton S; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon D; Addington J
    Psychiatry Res; 2016 Aug; 242():61-66. PubMed ID: 27259137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duration of untreated prodromal symptoms in a Chinese sample at a high risk for psychosis: demographic, clinical, and outcome.
    Zhang T; Xu L; Tang Y; Cui H; Wei Y; Wang J; Tang X; Li C; Wang J
    Psychol Med; 2018 Jun; 48(8):1274-1281. PubMed ID: 29173206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring specific predictors of psychosis onset over a 2-year period: A decision-tree model.
    Bjornestad J; Tjora T; Langeveld JH; Stain HJ; Joa I; Johannessen JO; Friedman-Yakoobian M; Ten Velden Hegelstad W
    Early Interv Psychiatry; 2022 Apr; 16(4):363-370. PubMed ID: 33991405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treating young individuals at clinical high risk for psychosis.
    Marshall C; Addington J; Epstein I; Liu L; Deighton S; Zipursky RB
    Early Interv Psychiatry; 2012 Feb; 6(1):60-8. PubMed ID: 21951980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High remission rates from an initial ultra-high risk state for psychosis.
    Simon AE; Umbricht D
    Schizophr Res; 2010 Feb; 116(2-3):168-72. PubMed ID: 19854621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.
    Carrión RE; Demmin D; Auther AM; McLaughlin D; Olsen R; Lencz T; Correll CU; Cornblatt BA
    J Psychiatr Res; 2016 Oct; 81():95-101. PubMed ID: 27424062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Early Psychosis Screener for Internet (EPSI)-SR: Predicting 12 month psychotic conversion using machine learning.
    Brodey BB; Girgis RR; Favorov OV; Bearden CE; Woods SW; Addington J; Perkins DO; Walker EF; Cornblatt BA; Brucato G; Purcell SE; Brodey IS; Cadenhead KS
    Schizophr Res; 2019 Jun; 208():390-396. PubMed ID: 30777603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion.
    Mamah D; Mutiso VN; Ndetei DM
    Schizophr Res; 2022 Mar; 241():201-209. PubMed ID: 35144059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.
    Azis M; Strauss GP; Walker E; Revelle W; Zinbarg R; Mittal V
    Schizophr Bull; 2019 Sep; 45(5):1042-1050. PubMed ID: 30535399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognition in help-seeking individuals at risk for psychosis: Prediction of outcome after 24 months.
    Metzler S; Dvorsky D; Wyss C; Nordt C; Walitza S; Heekeren K; Rössler W; Theodoridou A
    Psychiatry Res; 2016 Dec; 246():188-194. PubMed ID: 27718468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.